Cardiology Associations

This page includes news coverage of cardiology societies and associations. Follow these links for specific cardiology society news pages: American College of Cardiology (ACC), American Heart Association (AHA), American Society of Echocardiography (ASE), American Society Nuclear Cardiology (ASNC), European Society of Cardiology (ESC), Heart Rhythm Society (HRS), Society for Cardiovascular Angiography Interventions (SCAI), Society of Cardiovascular Computed Tomography (SCCT), Transcatheter Cardiovascular Therapeutics (TCT), and Vascular Interventional Advances (VIVA).

Medical societies respond after Trump administration questioned necessity of certain procedures
A recent OIG report suggested many vascular surgeons, interventional cardiologists and interventional radiologists may be performing medically unnecessary vascular procedures in office-based labs. Now, some of the leading medical societies from those very fields have shared a statement to provide additional context.
What every cardiologist should consider before signing a contract
Cathie Biga, MSN, a former ACC president, says salary is just one thing a cardiologist should ask about before signing any contract.
SAPT after TAVR linked to key benefits over DAPT, new data confirm
All-cause mortality after six months was significantly lower for patients discharged on SAPT. That trend remained in place after 24 months.
American Heart Association takes on cardiac amyloidosis with new initiative
One of the project's biggest goals is helping clinicians identify patients in need of care earlier than ever.
Have clinicians been wrong about how they diagnose PAD?
The ankle-brachial index, a noninvasive diagnostic test for peripheral artery disease, may provide even more value than clinicians previously realized.

Confirmed: Long COVID more than doubles a person’s risk of heart issues

According to a new analysis of data from nearly six million patients, experiencing long-lasting COVID-19 symptoms more than doubles the risk of cardiac complications.

Tim Attebery, DSc, MBA, the CEO of Cardiovascular Associates of America and former CEO of the American College of Cardiology (ACC)

Q&A: Tim Attebery on why private equity-backed management companies are investing in cardiology

The CEO of Cardiovascular Associates of America, and former CEO of the American College of Cardiology, shared his perspective on the rise of private equity investments in cardiology.

New ACC/AHA/SCAI guidance highlights training requirements for interventional cardiologists

The document, which was designed to help guide both interventional cardiology trainees and program directors, was also endorsed by several other industry societies.

Bertram Pitt, MD, a professor of medicine emeritus at the University of Michigan School of Medicine, explains the role of sodium–glucose co-transporter-2 (SGLT-2) inhibitors for heart failure (HF). Initially developed to treat diabetes, these drugs have been shown to improve HF outcomes in HF in several large, randomized trials over the past few years, including SOLOIST-WHF, DAPA-HF, EMPEROR-Preserved, and the DELIVER trials. The positive results earned their inclusion in the 2022 AHA/ACC/HFSA Guideline for

What clinical research tells us about sotagliflozin and heart failure

Some SGLT2 inhibitors have been linked to significant improvements in HF outcomes, but what about sotagliflozin? We spoke with Bertram Pitt, MD, to learn more.

AHA President Michelle Albert explains what can be done to boost healthcare equity and diversity in cardiology.

AHA President Michelle Albert on addressing health equity issues in cardiology

American Heart Association President Michelle Albert, MD, talked to us about about how to address health inequities in cardiology departments.

ACC urges all interventional cardiologists to use intravascular imaging during PCI

New recommendations from the American College of Cardiology detail how intravascular imaging can help clinicians before, during and after PCI procedures.

Ed Nicol, MD, consultant cardiologist and honorary senior clinical lecturer with Kings College London and president-elect of the Society of Cardiovascular Computed Tomography (SCCT), explained artificial intelligence (AI) in cardiac CT is here to stay and its use is expanding. He noted that one AI-based algorithm is already included in recent cardiology guidelines and more will likely follow. #SCCT

Cardiac imagers need to understand AI as it enters clinical use and ACC guidelines

Most FDA-cleared AI algorithms are related to radiology and cardiology, meaning radiologists and cardiologists need to make an effort to learn how these technologies work.

High-risk patients ineligible for bypass surgery see ‘profound improvements’ after PCI

High-risk patients with complex CAD who are ineligible for CABG can still see substantial benefits from PCI.

Cardiology Associations

Medical societies respond after Trump administration questioned necessity of certain procedures

What every cardiologist should consider before signing a contract

SAPT after TAVR linked to key benefits over DAPT, new data confirm

American Heart Association takes on cardiac amyloidosis with new initiative

Have clinicians been wrong about how they diagnose PAD?